Gedeon Richter PLC (GDRB)

Budapest
Currency in HUF
10,360.0
+90.0(+0.88%)
Closed·
GDRB Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
Unusual trading volume
Fair Value
Day's Range
10,270.010,380.0
52 wk Range
9,205.011,260.0
Key Statistics
Edit
Bid/Ask
10,300.00 / 10,360.00
Prev. Close
10,270
Open
10,280
Day's Range
10,270-10,380
52 wk Range
9,205-11,260
Volume
494.01K
Average Volume (3m)
228.97K
1-Year Change
11.4%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GDRB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12,381.2
Upside
+19.51%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Gedeon Richter PLC News & Analysis

Show more

Gedeon Richter PLC Company Profile

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products in Europe, the Asia Pacific, North and Latin America, and internationally. It operates through two segments, Pharmaceuticals; and Wholesale and Retail. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, which are emergency contraceptive pills; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound healing; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergies; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; and Oralsept, a sore throat and local anesthetic. Further, it engages in the provision of financial accounting, social and welfare, portfolio and management, catering, carriage transportation, engineering, quality control, asset management, and biotechnological manufacturing and research services; pharmaceutical retail; trading of biotech products; and sale of medical equipment. The company has strategic co-development and license agreement with Adalvo Ltd. for a proposed bioequivalent to Semaglutide injection, a GLP-1 receptor agonist indicated for chronic weight management. The company was formerly known as Gedeon Richter Ltd. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.

Employees
10943
Market
Hungary

Compare GDRB to Peers and Sector

Metrics to compare
GDRB
Peers
Sector
Relationship
P/E Ratio
7.9x7.9x−0.5x
PEG Ratio
0.280.030.00
Price/Book
1.4x0.8x2.6x
Price / LTM Sales
2.2x1.2x3.0x
Upside (Analyst Target)
19.7%53.6%52.4%
Fair Value Upside
Unlock31.2%8.7%Unlock

Analyst Ratings

7 Buy
2 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 12,381.2
(+19.51% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,307.18%
Dividend Yield
4.91%
Industry Median 6.66%
Annualised payout
508.56
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 13, 2025
EPS / Forecast
373.00 / --
Revenue / Forecast
224.02B / --
EPS Revisions
Last 90 days

GDRB Income Statement

People Also Watch

27,070.0
OTPB
+1.61%
2,994.0
MOLB
+0.94%
1,757.500
RHMG
+2.12%
1,800.0
MTEL
+0.67%
1,072.0
WIZZ
+1.52%

FAQ

What Stock Exchange Does Gedeon Richter Trade On?

Gedeon Richter is listed and trades on the Budapest Stock Exchange stock exchange.

What Is the Stock Symbol for Gedeon Richter?

The stock symbol for Gedeon Richter is "GDRB."

What Is the Gedeon Richter Market Cap?

As of today, Gedeon Richter market cap is 1.89T.

What Is Gedeon Richter's Earnings Per Share (TTM)?

The Gedeon Richter EPS (TTM) is 1,307.18.

When Is the Next Gedeon Richter Earnings Date?

Gedeon Richter will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is GDRB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Gedeon Richter Stock Split?

Gedeon Richter has split 1 times.

How Many Employees Does Gedeon Richter Have?

Gedeon Richter has 10943 employees.

What is the current trading status of Gedeon Richter (GDRB)?

As of 22 Jun 2025, Gedeon Richter (GDRB) is trading at a price of 10,360.00, with a previous close of 10,270.00. The stock has fluctuated within a day range of 10,270.00 to 10,380.00, while its 52-week range spans from 9,205.00 to 11,260.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.